Abstract Peripheral T cell lymphomas are aggressive neoplasms with an overall bad prognosis. As occurred with B cell lymphomas, some T cell lymphomas have been correlated with a normal T cell counterpart. According to the actual WHO classification of tumors of hematopoietic and lymphoid tissues, the only T cell lymphoma characterized by a T reg phenotype is adult T cell leukemia/ lymphoma (ATCLL), an entity defined by its etiologic association with HTLV-1 infection. We present a case of peripheral T cell lymphoma with a Treg phenotype not associated with HTLV-1 infection. We describe its pathological and clinical characteristics and discuss the presence of a T reg phenotype in T cell lymphomas.
Introduction
Peripheral T cell lymphomas (PTCL) are aggressive neoplasm's characterized by an overall poor prognosis.
Regulatory T cells (T regs ) are a subpopulation of T helper lymphocytes specialized in suppressing inflammatory responses. They suppress proliferation and activation of other T cells, maintaining the balance between immunity and tolerance. Their presence as part of the inflammatory reaction to some neoplastic disorders has been associated with a weaker cytotoxic immunologic response to tumors but also, for some entities, with a better prognosis [1] [2] [3] . T regs are characterized by the expression of the forkhead transcription factor family member: FOXP3; they also express surface cell markers like CD4 and CD25, all easily detected by immunohistochemical methods [3] .
As occurred with B cell lymphomas, efforts have been made to correlate PTCLs with a normal T cell counterpart. For example, anaplastic large cell lymphoma (ALCL), enteropathy-associated T cell lymphoma (EATL), and subcutaneous panniculitis-like T cell lymphoma are thought to derive from an effector/memory CD8 + T cell, mycosis fungoides from effector CD4 + T cells, and angioimmunoblastic lymphoma (AIL) from follicular helper (T FH ) T cells [4] . Exemptions are not rare and phenotypic plasticity is a well-recognized problem when trying to classify T cell lymphomas.
As a group, PTCL not otherwise specified (NOS) remain poorly understood. While early studies failed to classify PTCL NOS according to a CD8/cytotoxic or a CD4/helper immunophenotype, a gene expression profiling (GEP) study published in 2007 by Piccaluga et al. found that overall, the PTCL-NOS gene expression pattern was more similar to activated CD4 T cells, with only a minority of cases resembling activated CD8 T cells. Interestingly, immunophenotypic analysis for CD4 and CD8 did not correlate with different GEP groups [5, 6] .
According to the actual WHO classification of tumors of hematopoietic and lymphoid tissues, the only T cell lymphoma characterized by a T reg phenotype is adult T cell leukemia/lymphoma (ATLL), an entity defined by its etiologic association with HTLV-1 infection; in spite of this some cutaneous T cell lymphomas (CTCL) and at least three cases of PTCL NOS with a T reg phenotype have been reported (one from Germany and two from South America), these cases were not associated with HTLV-1 infection [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .
We report a case of PTCL NOS showing a bona fide T reg phenotype, and review the pertinent literature.
Clinical history
A 61-year-old woman presented with a 2-month history of intermittent abdominal pain and lower limb edema. Physical examination revealed a palpable abdominal mass. The CT-scan documented a circumferential wall thickening of the small-bowel that was 25-cm long affecting the proximal and middle jejunum. Multiple mesenteric, aortic, and retroperitoneal lymphadenopathies were also noted; hepatosplenomegaly was absent. No history of chronic diarrhea, malabsorption, weight loss, or fever was reported.
Complete blood count showed 4.6×10 9 /L leukocytes, with a normal differential hemoglobin of 8 g/dL, and a platelet count of 455×10 9 /L. The liver enzymes were within normal limits, and the lactate dehydrogenase level was 130 IU/mL.
Biopsies from the intestinal lesion were reported as PTCL, NOS, with a T reg phenotype. The bone marrow biopsy did not show infiltration. Her Ann Arbor Stage was III AE with a lowintermediate International Prognostic Index risk and a good performance status.
The patient was treated with standard doses of CHOEP and achieved a complete remission after six cycles. Twelve months later, she presented with fever, weight loss, and diaphoresis; a colonic recurrence was documented and treated by ICE (ifosfamide, carboplatin, and etoposide). The patient suffered from severe ifosfamide toxicity and nonconvulsive epilepsy that was aggravated by pneumonia. She died 21 months after the diagnosis.
Materials and methods
Routine hematoxylin and eosin (H&E) sections were prepared using standard techniques from formalin-fixed paraffin blocks. Immunohistochemical analyses included the following monoclonal antibodies: CD3, CD20, LMP-1 (BioSB) CD4, CD7, CD5, CD30, TIA 1 (Biocare), CD56 (Dako), CD8 (NeoMarkers), PD-1 (cell marque), CD25 (Novocastra), CD10, BCL-6, Granzyme B, and FOXP3 (Abcam).
In situ hybridization for EBV-encoded RNA (EBER) was performed on the biopsy. The EBER detection kit was purchased from Dako (Glostrup, Denmark). The detection process was conducted according to the manufacturer's instructions.
T cell clonality: DNA was extracted from formalin-fixed, paraffin-embedded tissue sections. This purified DNA was used to assay for clonal rearrangements of the T cell receptor (TCR) γ genes by polymerase chain reaction (PCR) using the method described by McCarthy et al. [17] .
Molecular detection of HTLV-1: DNA was extracted from formalin-fixed, paraffin-embedded tissue sections. PCR was performed using primers that detect the TAX and long terminal repeat (LTR) regions of HTLV-1 as follows:
HTLV-tax-F: 5′-GGATACCCAGTCTACGTGTTTG-3′ HTLV-tax-R: 5′-CGGAACATTGGTGAGGAAGGC-3′ HTLV-LTR-F: 5′-CCAGACTAAGGCTCTGACGTCT C-3′ HTLV-LTR-R: 5′-CCTGAGCTCTAAACTTACCTAG ACG-3′ Products were examined using polyacrylamide gel electrophoresis [18] .
Results
The jejunal endoscopic biopsy revealed a monotonous lymphoma diffusely infiltrating and expanding the lamina propria ( Fig. 1) . The tumor cells were large-to medium-sized lymphocytes with round nuclei, fine chromatin, and 1-3 visible nucleoli. Mitotic activity was high. A moderate villous atrophy without ulceration was noted; interestingly, intraepithelial lymphocytes (IELs) were nearly absent and tumor-infiltrating lymphocytes were sparse. All biopsies lacked normal intestinal mucosa. The colonic recurrence showed the same cohesive morphology with few tumor-infiltrating lymphocytes.
Immunohistochemically, the tumor cells expressed T cell markers (CD3, CD5, and CD7) and a T reg phenotype characterized by diffuse positivity for CD4, CD25, and FOXP3. A T FH immunophenotype was explored using PD-1, BCL-6, and CD10; all three antibodies were negative. Cytotoxic markers (CD8, Granzyme B, and TIA-1) were negative within the tumor and positive in IELs. Tumor infiltrating lymphocytes included B and T mature lymphocytes. Tumor cells were also negative for CD20, CD56, CD30, LMP-1, and EBER in situ hybridization.
Analysis by PCR of paraffin-embedded tissue showed clonal rearrangements of the TCR-γ (data not shown). A PCR for HTLV-1 was performed using DNA extracted from negative and positive controls and the patient's biopsy. While a band at the correct position with both primer sets was found in the positive control, no amplification was found in the patient's specimen, indicating that this lymphoma is not associated with HTLV-1 infection (Fig. 2) .
The differential diagnosis included T/NK T cell lymphoma, a common entity in Central/South America, characterized by frequent extranodal presentation, yet negativity for CD56, cytotoxic markers, and EBER in situ hybridization, excluded it.
Moderate villous atrophy and large cell morphology seen in the jejunal biopsy could suggest a diagnosis of EATL; neither type I nor type II variants are characterized by a CD4 immunophenotype, the first being generally CD4-, CD8-, CD30 + and the second CD4-, CD8 the lack of chronic diarrhea or malabsorption history discouraged this diagnosis. Negativity for CD30 excluded ALCL. [7, 19] .
Recently, cases of primary small intestinal CD4 + T cell lymphomas with an indolent behavior have been described; all reported cases, originally diagnosed as refractory celiac disease, presented with diarrhea and weight loss, which was absent in our case. These cases were composed of small-to medium-sized lymphocytes with a low proliferative index, infiltrating the lamina propria, which is concordant with an indolent behavior; moreover, all cases were negative for T reg markers (CD25 Foxp3) and featured CD4 + IELs [20, 21] . Morphologic, immunophenotipic, and clinical differences excluded this diagnosis.
Discussion
We describe a case of PTCL NOS with a full T reg phenotype that histologically resembles other three cases previously reported (from Peru and Germany) ( Table 1) . Morphologically, all cases share a monotonous neoplastic infiltrate constituted by cohesive large size, "immunoblastic-like" cells, with prominent nucleoli and [7, [22] [23] [24] [25] [26] . Recently, some groups have challenged this point of view, considering that HTLV-1 can induce via its Tax protein both an increased circulating nontumoral T reg population and an increased FOXP3 expression in infected cells [27] . Another study found that only 36 % (60 of 169) of ATLL cases from Japan showed FOXP3 expression in lymphoma cells [28] , supporting the idea that the T reg phenotype could be induced rather than being present from the beginning [27] .
Our case lacked most of the clinical manifestations expected for the chronic, smoldering, acute, or lymphomatous forms of ATLL. Lymphocytosis with peripheral blood circulating cells, cutaneous lesions, bone lesions, hypercalcemia, hepatosplenomegaly, and bone marrow infiltration were all absent [7] .
The prevalence of HTLV-1 infection in the general Mexican population has not yet been defined. In America, it is known that Brazil, Colombia, Peru, and the Caribbean are endemic areas (2-10 % of their healthy adult population is infected). The virus has also been reported in Ecuador, Paraguay, Chile, and Argentina [29] . The largest survey done in Mexican population analyzed 1,078 serum samples of different risk groups, from 6 Mexican states. Of these, only 12 were positive by agglutination test and none was positive by Western blot analysis; other studies have confirmed this low prevalence in the north of the country [30, 31] . All these factors and a negative PCR test for HTLV-1 infection discouraged a diagnosis of ATLL.
Bonzheim et al. analyzed 83 PTCL: 32 PTCL NOS, 23 AIL, 20 ALCL (14 ALK-and 6 ALK+), and 8 other types of T cell lymphoma (2 cutaneous, 4 intestinal, 1 hepatosplenic, and 1 T/NK-cell lymphoma, nasal type), and found only 1 case with diffuse FOXP3 immunohistochemical positivity. Histologically, their case was also characterized by a diffuse growth pattern of medium and large atypical T cells with prominent nucleoli, being originally diagnosed, according to the Kiel classification, as the immunoblastic variant of PTCL-NOS. As in our case, this case showed a scant reactive inflammatory background, which the authors remarked as unusual among PTCL, evoking a possible inhibitory roll derived from a retained T reg cell function of the neoplastic cells.
Immunohistochemically, their case was diffusely positive for FOXP3 and CD4 while negative for CD25. As in the present case, HTLV-1 proviral DNA was not amplifiable by PCR. The patient died during the chemotherapy-induced neutropenic phase due to repeated infections 1 month after the diagnosis. The authors speculated that T reg function might have significantly suppressed antitumor immunity, which contributed to progression. They concluded that this rare phenotype could represent an adverse risk factor in PTCL-NOS [15] .
Two similar cases from Peru were reported by Brady et al.; in both cases, the lymphoma was composed of large cohesive cells, with clear cytoplasm, vesicular nuclei, and visible nucleoli. The first case was positive for FOXP3+ and CD25+ but lacked CD4, while the second case showed the same full T reg phenotype present in our case. These cases, as described in other T cell lymphomas, showed large Reed-Sternberg-like cells positive for EBER in situ hybridization; EBV activation being possibly induced by a T reg -associated immunosuppression [16, 32, 33] . The present case lacked Reed-Sternberg-like cells, EBV infection, or other signs of immunosuppression.
These four cases of PTCL NOS with a T reg phenotype showed variable clinical features; they all had different clinical stages, nodal and/or extranodal manifestations, and presented with or without B symptoms. The three cases from Central/ South America showed a complete initial remission followed by variable progression-free survivals (7 months, 1 year, and 2 years); the three cases relapsed and patients died 36, 21, and 46 months after diagnosis, respectively. None of these cases reached a 5-year survival, known to be of 30 % in PTCL NOS, thereby suggesting a still worse prognosis for this phenotype [19] .
A T reg phenotype has also been claimed in some CTCL and ALCL. Berger et al. described in vitro transformation of CTCL cells to a T reg phenotype after stimulation by immature dendritic cells charged with CTCL apoptotic debris [8] . A further study found increased levels of FoxP3 in peripheral blood mononuclear cells (PBMCs) of 3 of 12 HTLV-1 negative CTCL patients by quantitative real-time PCR [34] . Another study using the same technique analyzed 28 CTCL, 25 Sezary syndromes (SS), and 3 MF, and found 6 SS cases with extremely high expression levels for FoxP3 and CD25 [11] . A German study found FOXP3 expression in 4 of 5 MF with large cell transformation; these results are hampered by an exclusive cytoplasmic FOXP3 positivity seen in all figures [13] .
Further studies using immunohistochemistry and FACS have showed that CTCL are generally negative for FOXP3 and that the proportion of T regs in dermal infiltrates and peripheral blood varies among cases; Klemke et al. found significantly lower numbers of T regs in biopsies and peripheral blood of patients with SS, carrying a worse prognosis than MF [35] . Gjerdrum et al. analyzed 86 patients with MF and CTCL unspecified and found that all cases were negative for FOXP3; nevertheless, they found that cases with increasing numbers of tumor infiltrating T regs had a better prognosis [9] .
A study from Denmark found FOXP3 immunohistochemical expression in 1 of 13 cutaneous ALCL (C-ALC) analyzed; in this case, staining was intense, nuclear, and diffuse. They also found rare positive tumor cells in a case of lymphomatoid papulosis (LyP) and two other C-ALCL cases [12] .
FOXP3 expression has been also reported in ALCL; Kasprzycka et al. demonstrated elevated expression in 4 of 4 ALK + ALCL cell lines by real-time quantitative PCR; they also showed that lymphoid cells transfected with NPM/ALK acquired a T reg cell phenotype [36] . Bonzheim et al. described FOXP3 positivity in 4 of 6 ALK + ALCL and in 1 of 14 ALK-ALCL. In these cases, only 20 to 30 % of tumor cells showed weak and variable immunohistochemical positivity for FOXP3, which was not followed by positivity for other T reg markers. In view of these findings, the authors considered FoxP3 expression as aberrant instead of a part of a true T reg phenotype [15] .
We report a fourth case of PTCL NOS with a bona fide T reg phenotype not associated with HTLV-1 infection. We agree with previous reports that the morphology and immunophenotype of this tumor could eventually place it as a separate entity. In view that three of these cases come from Central/South America, further studies are necessary to establish the real frequency of this phenotype in PTCL NOS from this population.
